Hematopoietic Cell Transplantation and Cellular Therapy Fellowship

Tandem 2026
- Meet and Greet at City of Hope Booth

Friday, February 6th, from 10-10:30 am, Mountain Time

City of Hope Booth #112
- Located in Hall D

The Hematology Department at City of Hope (COH) offers a one-year Hematopoietic Cell Transplantation and Immune Effector Cell (HCT/IEC) fellowship for physicians who desire advanced training in clinical HCT and cellular therapy with an option of a second year of training in translational and clinical research. COH performs the highest number of allogeneic HCT in the U.S. and is also one of the highest volume IEC centers.

This fellowship provides extensive clinical training in all aspects of HCT including patient selection, HLA typing, assessment and management of toxicities, donor and graft selection. Furthermore, fellows will also be trained in IEC therapy which includes but is not limited to CAR‑T therapy and will gain competency in patient assessment, product selection, and management of complications associated with various IEC products across a variety of indications including experimental products in both hematologic and solid malignancies.

In addition to an in-depth clinical experience at a high-volume center, fellows will also be provided protected time to perform clinical and translational research. These efforts are led by world-renowned clinical, translational, and basic science faculty. Furthermore, ample opportunity exists for multidisciplinary research with faculty in diverse areas such as immuno‑oncology, stem cell biology, gene therapy, aging, precision medicine, and infectious diseases.

City of Hope, a National Cancer Institute-designated comprehensive cancer center and a member of the Southwest Oncology Group is comprised of world class scientific leaders who continue to pioneer and develop breakthrough immunotherapies. It is one of the oldest and largest transplant centers in the country performing over 800 stem cell transplants and 300 CAR‑T infusions per year. On the strength of its scientific and clinical programs, it has most recently garnered a top 5 ranking according to the U.S. News and World Report among U.S. cancer centers.

• At the time of entry into the fellowship program all applicants will be board certified in internal medicine, and board certified or board eligible in hematology/oncology.

Candidates should submit a cover letter, curriculum vitae, and three letter of references (one of whom should be the director of the candidate current fellowship) to the HCT Fellowship Program Administrator at okiedpool

Karamjeet Singh Sandhu, MD
Program Director
Assistant Professor
1500 E Duarte Road
Duarte, CA 91010
ksandhu

Ofelia Kiedpool, MSEd, C‑TAGME
Program Administrator
1500 E Duarte Road
Duarte, CA 91010
okiedpool